Paladin Wealth LLC Has $732,000 Stake in Lam Research Corporation $LRCX

Paladin Wealth LLC trimmed its stake in Lam Research Corporation (NASDAQ:LRCX) by 43.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,277 shares of the semiconductor company’s stock after selling 3,231 shares during the period. Paladin Wealth LLC’s holdings in Lam Research were worth $732,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LRCX. PMV Capital Advisers LLC acquired a new position in Lam Research during the fourth quarter valued at approximately $25,000. Stance Capital LLC bought a new position in shares of Lam Research in the third quarter valued at approximately $26,000. Triumph Capital Management acquired a new stake in shares of Lam Research in the third quarter worth $27,000. Harbor Investment Advisory LLC lifted its stake in shares of Lam Research by 73.9% in the fourth quarter. Harbor Investment Advisory LLC now owns 240 shares of the semiconductor company’s stock worth $41,000 after buying an additional 102 shares during the last quarter. Finally, Howard Hughes Medical Institute bought a new stake in shares of Lam Research during the 2nd quarter worth $27,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

LRCX has been the topic of a number of research analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $320.00 target price (up from $265.00) on shares of Lam Research in a research note on Thursday, January 29th. HSBC boosted their target price on shares of Lam Research from $181.00 to $221.00 and gave the stock a “hold” rating in a research report on Friday, January 30th. KeyCorp reaffirmed a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. Wells Fargo & Company lifted their price objective on Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Finally, Rothschild & Co Redburn boosted their price objective on Lam Research from $225.00 to $265.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $245.35.

Insider Transactions at Lam Research

In related news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the transaction, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total transaction of $333,990.00. Following the sale, the insider owned 53,205 shares in the company, valued at $11,846,625.30. This represents a 2.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is owned by corporate insiders.

Lam Research Stock Performance

NASDAQ:LRCX opened at $199.93 on Tuesday. The firm’s 50-day moving average is $227.35 and its 200-day moving average is $183.00. The company has a market cap of $249.67 billion, a price-to-earnings ratio of 40.97, a PEG ratio of 2.28 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.61 and a current ratio of 2.26. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $256.68.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter last year, the company earned $0.91 earnings per share. The firm’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be given a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is currently 21.31%.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.